CF PHARMTECH 02652Hong Kong Stock Exchange

6.0555.30%( +0.305 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
CF PHARMTECH (02652) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
CF PharmTech, Inc.
Market
HKEX Main Board
Listing Date
2025-10-08
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000074R9
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)507.20M70/112
Net Profit (Last FY)2.91M56/125
ROE (Last FY)0.17%55/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
梁文青 Executive Director
李励 Executive Director
李旗 Executive Director
朱玉玉 Executive Director
张晶晶 Executive Director
蔡磊 Executive Director
易华 Executive Director
金坚 Executive Director
王丽娟 Executive Director
魏士荣 Executive Director
叶耘开 Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-26.

About this page

This page shows CF PHARMTECH (02652) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.